Pharmaceutical

FDA to phase out animal testing with AI and lab-based models

The FDA has announced plans to phase out animal testing in the development of monoclonal antibodies and other drugs.

Apr 12, 2025 - 06:00
FDA to phase out animal testing with AI and lab-based models
The FDA has announced plans to phase out animal testing in the development of monoclonal antibodies and other drugs.
Read the original article

Tags:

Previous Article

Pluri’s immune cell expansion technologies gain patents

Next Article

AstraZeneca’s oral breast cancer drug Truqap greenlit for NHS use

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Gene therapy makers wonder if they can make a profit in Europe. Patients fear being left behind — again

STAT+: Gene therapy makers wonder if they can make a pr...

Oct 4, 2023

Canada and Alberta governments to invest in Entos R&D facility

Canada and Alberta governments to invest in Entos R&D f...

Mar 13, 2025

How cell and gene therapy are evolving

How cell and gene therapy are evolving

May 31, 2024